Meningococcal C conjugate vaccine: The experience in England and Wales

This publication has 64 references indexed in Scilit:

• Immunogenicity of a Reduced Schedule of Meningococcal Group C Conjugate Vaccine Given Concomitantly with the Prevenar and Pediacel Vaccines in Healthy Infants in the United Kingdom
  Clinical and Vaccine Immunology, 2009
• Seroprevalence of Antibodies against Serogroup C Meningococci in England in the Postvaccination Era
  Clinical and Vaccine Immunology, 2008
• Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study
  BMJ, 2008
• Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
  The Journal of Infectious Diseases, 2008
• No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome
  Archives of Disease in Childhood, 2007
• No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales
  The Lancet Infectious Diseases, 2006
• Haemophilus influenzaeType b Reemergence after Combination Immunization
  Emerging Infectious Diseases, 2006
• Recent emergence of serogroup C meningococcal disease in Greece
  FEMS Immunology & Medical Microbiology, 1999
• Increasing incidence of meningococcal disease in Spain associated with a new variant of serogroup C
  European Journal of Clinical Microbiology & Infectious Diseases, 1998
• Meningococcal vaccine in sub-Saharan Africa
  The Lancet, 1997